Spanish Supreme Court provides clarity on patent limitations during invalidity proceedings

In a recent judgment, the Supreme Court clarifies the procedural practice for defendants to raise a patent limitation during invalidity proceedings. In this particular case, the invalidity related to addition of subject matter and lack of inventive step on the patent of the Tiotropium drug.

Background and summary of the case

The case was brought in 2012 by Laboratorios Liconsa S.A. (“Liconsa”) against Boehringer Ingelheim Pharma GmbH &Co (“Boehringer”) before the Barcelona Patent court.

Liconsa filed invalidity proceedings for revocation of Boehringer's patent EP 1.379.220 , validated in Spain under number

Full article available on PatentHub

Latest insights

More Insights
featured image

Employment Litigation in Singapore: Employees Can Double-Strike with Employment Claims Tribunal Win Followed by High Court Claim

4 minutes Jul 11 2025

Read More
Curiosity line blue background

Sprinting to an IPO? ASIC trials a streamlined fast-track to the ASX

Jul 08 2025

Read More
featured image

Report of Trade Mark Cases For the CIPA Journal May 2025

1 minute Jul 04 2025

Read More